{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:53:24Z","timestamp":1774360404938,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"am","delay-in-days":307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007659","name":"Bayer Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K11371"],"award-info":[{"award-number":["JP19K11371"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K17094"],"award-info":[{"award-number":["JP20K17094"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.placenta.2024.07.001","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:12:06Z","timestamp":1719965526000},"page":"129-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Fibroblasts activation by embryonic signal switching: A novel mechanism of placental growth factor-induced cardiac remodeling"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0714-6980","authenticated-orcid":false,"given":"Lisa","family":"Kitasato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minako","family":"Yamaoka-Tojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Machika","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Iwaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Ogiso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Hashikata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonoka","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Tokui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Naraba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mototsugu","family":"Nishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidero","family":"Kitasato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Ako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.placenta.2024.07.001_bib1","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.placenta.2024.07.001_bib2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pharmthera.2011.12.010","article-title":"Post-infarct cardiac rupture: recent insights on pathogenesis and therapeutic interventions","volume":"134","author":"Gao","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.placenta.2024.07.001_bib3","first-page":"31","article-title":"Structure, expression and receptor-binding properties of placenta growth factor (PlGF)","volume":"237","author":"Persico","year":"1999","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"12","key":"10.1016\/j.placenta.2024.07.001_bib4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/jhh.2017.61","article-title":"Placental growth factor and pre-eclampsia","volume":"31","author":"Chau","year":"2017","journal-title":"J. Hum. Hypertens."},{"issue":"41","key":"10.1016\/j.placenta.2024.07.001_bib5","doi-asserted-by":"crossref","first-page":"25646","DOI":"10.1016\/S0021-9258(18)47298-5","article-title":"Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1\/KDR","volume":"269","author":"Park","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.placenta.2024.07.001_bib6","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.jacc.2005.11.064","article-title":"Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction","volume":"47","author":"Iwama","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.placenta.2024.07.001_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2007.10.050","article-title":"Elevation of plasma placental growth factor in the patients with ischemic cardiomyopathy","volume":"131","author":"Nakamura","year":"2009","journal-title":"Int. J. Cardiol."},{"issue":"12","key":"10.1016\/j.placenta.2024.07.001_bib8","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1161\/CIRCULATIONAHA.111.050500","article-title":"Placental growth factor regulates cardiac inflammation through the tissue inhibitor of metalloproteinases-3\/tumor necrosis factor-alpha-converting enzyme axis: crucial role for adaptive cardiac remodeling during cardiac pressure overload","volume":"124","author":"Carnevale","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.placenta.2024.07.001_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1536\/ihj.54.133","article-title":"Soluble Fms-like tyrosine kinase 1 is a novel predictor of brain natriuretic peptide elevation","volume":"54","author":"Kameda","year":"2013","journal-title":"Int. Heart J."},{"issue":"8","key":"10.1016\/j.placenta.2024.07.001_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tcm.2012.05.014","article-title":"Placental growth factor as a protective paracrine effector in the heart","volume":"21","author":"Accornero","year":"2011","journal-title":"Trends Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.placenta.2024.07.001_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00001573-199707000-00002","article-title":"Update on local cardiac renin-angiotensin system","volume":"12","author":"Ruzicka","year":"1997","journal-title":"Curr. Opin. Cardiol."},{"issue":"5","key":"10.1016\/j.placenta.2024.07.001_bib12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1536\/ihj.15-112","article-title":"Rivaroxaban inhibits angiotensin II-induced activation in cultured mouse cardiac fibroblasts through the modulation of NF-kappaB pathway","volume":"56","author":"Hashikata","year":"2015","journal-title":"Int. Heart J."},{"issue":"5","key":"10.1016\/j.placenta.2024.07.001_bib13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/CIRCRESAHA.116.304269","article-title":"Transcriptional reversion of cardiac myocyte fate during mammalian cardiac regeneration","volume":"116","author":"O'Meara","year":"2015","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.placenta.2024.07.001_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1536\/ihj.13-351","article-title":"Factor Xa in mouse fibroblasts may induce fibrosis more than thrombin","volume":"55","author":"Kitasato","year":"2014","journal-title":"Int. Heart J."},{"issue":"10","key":"10.1016\/j.placenta.2024.07.001_bib15","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1172\/JCI42028","article-title":"Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-\u03b2","volume":"120","author":"Teekakirikul","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.placenta.2024.07.001_bib16","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis","volume":"124","author":"Moore-Morris","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.placenta.2024.07.001_bib17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0735-1097(96)00140-4","article-title":"Role of oxidative stress in transition of hypertrophy to heart failure","volume":"28","author":"Dhalla","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.placenta.2024.07.001_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1871529X11313020010","article-title":"Oxidative stress and transforming growth factor-\u03b21-induced cardiac fibrosis","volume":"13","author":"Purnomo","year":"2013","journal-title":"Cardiovasc. Hematol. Disord.: Drug Targets"},{"issue":"9","key":"10.1016\/j.placenta.2024.07.001_bib19","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","article-title":"Multiple facets of NF-\u03baB in the heart: to be or not to NF-\u03baB","volume":"108","author":"Gordon","year":"2011","journal-title":"Circ. Res."},{"issue":"1\u20132","key":"10.1016\/j.placenta.2024.07.001_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.lfs.2014.04.030","article-title":"NF-\u03baB-mediated integrin-linked kinase regulation in angiotensin II-induced pro-fibrotic process in cardiac fibroblasts","volume":"107","author":"Thakur","year":"2014","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.placenta.2024.07.001_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0735-1097(01)01377-8","article-title":"Nuclear factor kappa-B and the heart","volume":"38","author":"Valen","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.placenta.2024.07.001_bib22","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0735-1097(96)00268-9","article-title":"Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension","volume":"28","author":"Testa","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.placenta.2024.07.001_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/08977199308991586","article-title":"A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta","volume":"9","author":"Hauser","year":"1993","journal-title":"Growth Factors"},{"issue":"3\u20134","key":"10.1016\/j.placenta.2024.07.001_bib24","article-title":"Localisation of placenta growth factor (PIGF) in human term placenta","volume":"13","author":"Khaliq","year":"1996","journal-title":"Growth Factors"},{"issue":"10","key":"10.1016\/j.placenta.2024.07.001_bib25","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/SMJ.0b013e3181eda4ef","article-title":"Placental growth factor as short-term predicting biomarker in acute coronary syndrome patients with non-ST elevation myocardial infarction","volume":"103","author":"Markovic","year":"2010","journal-title":"South. Med. J."},{"issue":"2","key":"10.1016\/j.placenta.2024.07.001_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jacc.2005.08.063","article-title":"Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes","volume":"47","author":"Lenderink","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.placenta.2024.07.001_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/CIRCRESAHA.111.240820","article-title":"Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism","volume":"109","author":"Accornero","year":"2011","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.placenta.2024.07.001_bib28","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1161\/01.CIR.92.12.3568","article-title":"Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats","volume":"92","author":"Ruzicka","year":"1995","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.placenta.2024.07.001_bib29","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCULATIONAHA.106.679589","article-title":"Mitogen-activated protein kinases in heart development and diseases","volume":"116","author":"Wang","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.placenta.2024.07.001_bib30","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","article-title":"Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells","volume":"74","author":"Griendling","year":"1994","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.placenta.2024.07.001_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.RES.77.1.29","article-title":"Differential activation of mitogen-activated protein kinases by H2O2 and O2- in vascular smooth muscle cells","volume":"77","author":"Baas","year":"1995","journal-title":"Circ. Res."},{"issue":"24","key":"10.1016\/j.placenta.2024.07.001_bib32","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1074\/jbc.273.24.15022","article-title":"p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy","volume":"273","author":"Ushio-Fukai","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.placenta.2024.07.001_bib33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/hh2001.098873","article-title":"ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts","volume":"89","author":"Sano","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.placenta.2024.07.001_bib34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1054-3589(08)60993-X","article-title":"Antioxidants, redox-regulated transcription factors, and inflammation","volume":"38","author":"Winyard","year":"1997","journal-title":"Adv. Pharmacol."},{"issue":"7","key":"10.1016\/j.placenta.2024.07.001_bib35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1096\/fasebj.10.7.8635688","article-title":"Antioxidant and redox regulation of gene transcription","volume":"10","author":"Sen","year":"1996","journal-title":"Faseb. J."},{"issue":"22","key":"10.1016\/j.placenta.2024.07.001_bib36","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1002\/j.1460-2075.1994.tb06878.x","article-title":"A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B","volume":"13","author":"Traenckner","year":"1994","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.placenta.2024.07.001_bib37","first-page":"6231","article-title":"Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop","volume":"13","author":"Hiscott","year":"1993","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.placenta.2024.07.001_bib38","first-page":"2327","article-title":"Activation of interleukin-6 gene expression through the NF-kappa B transcription factor","volume":"10","author":"Libermann","year":"1990","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.placenta.2024.07.001_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.171.1.35","article-title":"Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages","volume":"171","author":"Shakhov","year":"1990","journal-title":"J. Exp. Med."},{"issue":"31","key":"10.1016\/j.placenta.2024.07.001_bib40","doi-asserted-by":"crossref","first-page":"20067","DOI":"10.1016\/S0021-9258(17)32128-2","article-title":"NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress","volume":"269","author":"Wu","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.placenta.2024.07.001_bib41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.virol.2016.12.022","article-title":"NF-\u03baB activation is cell type-specific in the heart","volume":"502","author":"Rivera-Serrano","year":"2017","journal-title":"Virology"},{"issue":"18","key":"10.1016\/j.placenta.2024.07.001_bib42","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.CIR.0000015603.84788.47","article-title":"Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway","volume":"105","author":"Kalra","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.placenta.2024.07.001_bib43","first-page":"123","article-title":"[AMP-activated kinase activation inhibits transforming growth factor-beta1 production in cardiac fibroblasts via targeting C\/EBPbeta]","volume":"69","author":"Xiao","year":"2017","journal-title":"Sheng Li Xue Bao"},{"issue":"5","key":"10.1016\/j.placenta.2024.07.001_bib44","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/HYPERTENSIONAHA.118.12267","article-title":"HIMF (Hypoxia-Induced mitogenic factor)-IL (Interleukin)-6 signaling mediates cardiomyocyte-fibroblast crosstalk to promote cardiac hypertrophy and fibrosis","volume":"73","author":"Kumar","year":"2019","journal-title":"Hypertension"},{"issue":"82","key":"10.1016\/j.placenta.2024.07.001_bib45","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1046\/j.1523-1755.62.s82.4.x","article-title":"Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney","author":"Ruiz-Ortega","year":"2002","journal-title":"Kidney Int. Suppl."},{"issue":"6","key":"10.1016\/j.placenta.2024.07.001_bib46","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/01.RES.84.6.695","article-title":"Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors","volume":"84","author":"Han","year":"1999","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.placenta.2024.07.001_bib47","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.yjmcc.2007.09.003","article-title":"TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction","volume":"43","author":"Tian","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.placenta.2024.07.001_bib48","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1507\/endocrj.EJ17-0363","article-title":"Placental growth factor (PlGF) is linked to inflammation and metabolic disorders in mice with diet-induced obesity","volume":"65","author":"Kang","year":"2018","journal-title":"Endocr. J."},{"issue":"5","key":"10.1016\/j.placenta.2024.07.001_bib49","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.placenta.2003.11.001","article-title":"Deferential regulation of placenta growth factor (PlGF)-mediated signal transduction in human primary term trophoblast and endothelial cells","volume":"25","author":"Arroyo","year":"2004","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.placenta.2024.07.001_bib50","first-page":"135","article-title":"A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF","volume":"10","author":"Seetharam","year":"1995","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.placenta.2024.07.001_bib51","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.bbamcr.2007.03.010","article-title":"p38 MAP-kinases pathway regulation, function and role in human diseases","volume":"1773","author":"Cuenda","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.placenta.2024.07.001_bib52","doi-asserted-by":"crossref","first-page":"H934","DOI":"10.1152\/ajpheart.00206.2017","article-title":"Inhibitory actions of the NRG-1\/ErbB4 pathway in macrophages during tissue fibrosis in the heart, skin, and lung","volume":"313","author":"Vermeulen","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.placenta.2024.07.001_bib53","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101428RR","article-title":"Nrg1\/ErbB signaling-mediated regulation of fibrosis after myocardial infarction","volume":"36","author":"Shiraishi","year":"2022","journal-title":"Faseb. J."},{"issue":"6020","key":"10.1016\/j.placenta.2024.07.001_bib54","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.1200708","article-title":"Transient regenerative potential of the neonatal mouse heart","volume":"331","author":"Porrello","year":"2011","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.placenta.2024.07.001_bib55","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","article-title":"Dynamics of cell generation and turnover in the human heart","volume":"161","author":"Bergmann","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.placenta.2024.07.001_bib56","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1038\/s41467-023-41305-7","article-title":"Placental growth factor exerts a dual function for cardiomyogenesis and vasculogenesis during heart development","volume":"14","author":"Witman","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.placenta.2024.07.001_bib57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2121-11-36","article-title":"Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells","volume":"11","author":"Pan","year":"2010","journal-title":"BMC Cell Biol."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400424002960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400424002960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T22:03:11Z","timestamp":1725141791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400424002960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":57,"alternative-id":["S0143400424002960"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2024.07.001","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblasts activation by embryonic signal switching: A novel mechanism of placental growth factor-induced cardiac remodeling","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2024.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}